Screener
IDEAYA Biosciences, Inc. IDYA Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 115,104 | 84,389 |
| Loss from operations | (108,544) | (84,389) |
| Other income | ||
| Interest income and other income, net | 10,005 | 12,211 |
| Net loss | $(98,539) | $(72,178) |
| Unrealized (losses) gains on marketable securities | (2,761) | 773 |
| Comprehensive loss | $(101,300) | $(71,405) |
| Net loss per common share, basic and diluted | $(1.11) | $(0.82) |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s other income (expense)?
- IDEAYA Biosciences, Inc. (IDYA) reported other income (expense) of $10.01M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s other income (expense) changed year-over-year?
- IDEAYA Biosciences, Inc.'s other income (expense) decreased by 18.1% year-over-year, from $12.21M to $10.01M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s other income (expense) has grown at a 208.1% compound annual growth rate (CAGR), from $506K to $45.62M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about IDEAYA Biosciences, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude